News of the WeekClinical Research

AIDS Vaccine Results Draw Investor Lawsuits

See allHide authors and affiliations

Science  28 Mar 2003:
Vol. 299, Issue 5615, pp. 1965
DOI: 10.1126/science.299.5615.1965b

You are currently viewing the summary.

View Full Text

Summary

VaxGen, the Brisbane, California, biotech that came under scientific fire last month when it revealed results of the first-ever real-world trial of an AIDS vaccine, is now dodging legal bullets from investors.